1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Peripheral T-cell Lymphoma: new trials by email Literature Review of Peripheral T-cell Lymphoma trials Research Report on Peripheral T-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma PD-1 blocking antibody, chidamide, lenalidomide and gemcitabine - Peripheral T-cell Lymphoma | Phase 4 | Unknown | Mingzhi Zhang | 100 | 2019-09-01 | 2020-05-12 |
| Treatment of Peripheral T-cell Lymphoma GDPT regimen, CHOP regimen - Peripheral T-cell Lymphoma | Phase 4 | Completed | Mingzhi Zhang | 100 | 2011-08-01 | 2016-10-05 |
Lymphoma, T-Cell, Peripheral (2)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma, T-Cell (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
Gemcitabine (1) · Lenalidomide (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1) · VAP-cyclo protocol (1)
Mingzhi Zhang (2)
China (2)